1. Home
  2. DYN vs MNR Comparison

DYN vs MNR Comparison

Compare DYN & MNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYN
  • MNR
  • Stock Information
  • Founded
  • DYN 1984
  • MNR 2017
  • Country
  • DYN United States
  • MNR United States
  • Employees
  • DYN N/A
  • MNR N/A
  • Industry
  • DYN Medicinal Chemicals and Botanical Products
  • MNR
  • Sector
  • DYN Health Care
  • MNR
  • Exchange
  • DYN Nasdaq
  • MNR Nasdaq
  • Market Cap
  • DYN 1.4B
  • MNR 1.7B
  • IPO Year
  • DYN 2020
  • MNR 2023
  • Fundamental
  • Price
  • DYN $12.50
  • MNR $14.50
  • Analyst Decision
  • DYN Strong Buy
  • MNR Strong Buy
  • Analyst Count
  • DYN 15
  • MNR 3
  • Target Price
  • DYN $36.00
  • MNR $23.00
  • AVG Volume (30 Days)
  • DYN 3.0M
  • MNR 321.9K
  • Earning Date
  • DYN 07-28-2025
  • MNR 08-07-2025
  • Dividend Yield
  • DYN N/A
  • MNR 18.98%
  • EPS Growth
  • DYN N/A
  • MNR N/A
  • EPS
  • DYN N/A
  • MNR 1.95
  • Revenue
  • DYN N/A
  • MNR $930,939,000.00
  • Revenue This Year
  • DYN N/A
  • MNR $12.96
  • Revenue Next Year
  • DYN N/A
  • MNR $11.83
  • P/E Ratio
  • DYN N/A
  • MNR $7.45
  • Revenue Growth
  • DYN N/A
  • MNR 11.58
  • 52 Week Low
  • DYN $6.36
  • MNR $12.40
  • 52 Week High
  • DYN $47.45
  • MNR $20.94
  • Technical
  • Relative Strength Index (RSI)
  • DYN 70.49
  • MNR 42.75
  • Support Level
  • DYN $10.78
  • MNR $13.86
  • Resistance Level
  • DYN $12.59
  • MNR $14.55
  • Average True Range (ATR)
  • DYN 0.82
  • MNR 0.38
  • MACD
  • DYN 0.31
  • MNR -0.09
  • Stochastic Oscillator
  • DYN 78.35
  • MNR 30.81

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

About MNR Mach Natural Resources LP

Mach Natural Resources LP is an independent upstream oil and gas company. The company is focused on the acquisition, development and production of oil, natural gas, and NGL reserves in the Anadarko Basin region of Western Oklahoma, Southern Kansas, and the panhandle of Texas.

Share on Social Networks: